Dyne Therapeutics, Inc. (DYN)
17.90
+1.09
(+6.48%)
USD |
NASDAQ |
Jun 09, 16:00
17.90
0.00 (0.00%)
After-Hours: 19:16
Dyne Therapeutics SG&A Expense (Quarterly) : 24.39M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Vor Biopharma, Inc. | 17.56M |
| BioCryst Pharmaceuticals, Inc. | 94.55M |
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| Imunon, Inc. | 1.969M |